[Federal Register Volume 61, Number 152 (Tuesday, August 6, 1996)]
[Notices]
[Page 40864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-19945]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Senior Executive Service (SES) Performance Review Board; Notice 
of Establishment

SUMMARY: Notice is hereby given of the appointment of the ONDCP SES 
Performance Review Board.

EFFECTIVE DATE: August 1, 1996.

FOR FURTHER INFORMATION CONTACT: Edward H. Jurith, General Counsel, 
Office of National Drug Control Policy, Executive Office of the 
President, Washington, D.C. 2050; telephone: 202-395-6709; FAX: 202-
395-6708.

SUPPLEMENTARY INFORMATION: 5 U.S.C. 4314(c) requires each agency to 
establish, in accordance with regulations prescribed by the Office of 
Personnel Management at 5 CFR Part 430, subpart C and Sec. 430.307 
thereof in particular, one or more Senior Executive Service performance 
boards. As a small executive agency, ONDCP has just one board. The 
board shall review and evaluate the initial appraisal of each ONDCP 
senior executive's performance by his or her supervisor, the senior 
executive's written response, if any, along with any recommendations in 
each instance to the appointing authority relative to the performance 
of the senior executive.
    The following have been selected as regular members of the SES 
Performance Review Board for the Office of National Drug Control 
Policy:

Patricia A. Seitz (Chair), Assistant Director for Legal Affairs, Office 
of National Drug Control Policy
Dr. Albert E. Brandenstein, Director, Counter Drug Technology 
Assessment Center, Office of National Drug Control Policy
Dr. John T. Carnevale, Assistant Director for Programs, Budget and 
Research, Office of National Drug Control Policy

    Approved: July 17, 1996.
Janet Crist,
Chief of Staff, Office of National Drug Control Policy.
[FR Doc. 96-19945 Filed 8-5-96; 8:45 am]
BILLING CODE 3180-02-U